Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related

Authors: Sommer, Alexander, Weigel, Stefanie, Hense, Hans-Werner, Gerß, Joachim, Weyer-Elberich, Veronika, Kerschke, Laura, Nekolla, Elke, Lenzen, Horst, Heindel, Walter, for the TOSYMA Screening Trial Study Group, Hecht, Gerold, Czwoydzinski, Jörg

Source: Eur Radiol

Subject Terms: Breast Neoplasms, Middle Aged, Radiation Exposure, Radiation Dosage, Breast Neoplasms/diagnostic imaging [MeSH], Female [MeSH], Aged [MeSH], Early Detection of Cancer/methods [MeSH], Mass Screening/methods [MeSH], Humans [MeSH], Digital breast tomosynthesis, Middle Aged [MeSH], Breast cancer detection, Breast, Breast density, Breast/diagnostic imaging [MeSH], Radiation Exposure [MeSH], Mammography/methods [MeSH], Mammography screening, Breast Density [MeSH], Radiation Dosage [MeSH], Radiation exposure, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Mass Screening, Female, Early Detection of Cancer, Mammography, Aged, Breast Density

Access URL: https://pubmed.ncbi.nlm.nih.gov/39012526
https://repository.publisso.de/resource/frl:6523530

Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial.

Authors: Heindel, Walter¹ (AUTHOR) heindel@uni-muenster.de, Weigel, Stefanie¹ (AUTHOR), Gerß, Joachim² (AUTHOR), Hense, Hans-Werner³ (AUTHOR), Sommer, Alexander¹ (AUTHOR), Krischke, Miriam⁴ (AUTHOR), Kerschke, Laura² (AUTHOR), TOSYMA Screening Trial Study Group (CORPORATE AUTHOR)

Source: Lancet Oncology. May2022, Vol. 23 Issue 5, p601-611. 11p.

Subject Terms: *DIGITAL mammography, *TOMOSYNTHESIS, *CANCER invasiveness, *BREAST cancer, *MEDICAL screening, *LOBULAR carcinoma, *MAMMOGRAMS, *RESEARCH, *EARLY detection of cancer, *EVALUATION research, *COMPARATIVE studies, *RANDOMIZED controlled trials, *BREAST tumors, *LONGITUDINAL method

Geographic Terms: GERMANY

Company/Entity: DEUTSCHE Forschungsgemeinschaft

Surrogate endpoints in breast cancer screening trials - Authors' reply.

Authors: Heindel, Walter¹ (AUTHOR) heindel@uni-muenster.de, Weigel, Stefanie¹ (AUTHOR), Hense, Hans-Werner² (AUTHOR), TOSYMA Screening Trial Study Group (CORPORATE AUTHOR)

Source: Lancet Oncology. Aug2022, Vol. 23 Issue 8, pe361-e361. 1p.

Subject Terms: *EARLY detection of cancer, *BREAST cancer, *AUTHORS